methacycline has been researched along with Liver Steatosis in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (9.09) | 18.2507 |
2000's | 3 (27.27) | 29.6817 |
2010's | 5 (45.45) | 24.3611 |
2020's | 2 (18.18) | 2.80 |
Authors | Studies |
---|---|
Chabowski, A; Harasim-Symbor, E; Konstantynowicz-Nowicka, K; Sztolsztener, K | 1 |
Butterfield, DA; Deevska, G; Dotson, PP; Mitov, M; Nikolova-Karakashian, M | 1 |
Perry, RJ; Petersen, KF; Samuel, VT; Shulman, GI | 1 |
Albert, CJ; Brunt, EM; Chen, Z; Collier, SL; Finck, BN; Ford, DA; Graham, MJ; Hall, AM; Mathews, JC; Soufi, N; Yoshino, J | 1 |
Abudukadier, A; Akgul, EO; Bhanot, S; Guigni, B; Jornayvaz, FR; Jurczak, MJ; Kanda, S; Majumdar, SK; Manchem, VP; Petersen, KF; Popov, VB; Samuel, VT; Shulman, GI; Zhang, D | 1 |
Belury, MA; Liu, LF; Stout, MB | 1 |
Jornayvaz, FR; Shulman, GI | 1 |
Asai, T; Ito, M; Kamiya, H; Matsubara, K; Matsui, H; Murohara, T; Okumura, K; Saburi, Y; Takahashi, R | 1 |
Asai, T; Hirai, T; Ito, M; Matsui, H; Murakami, H; Murakami, R; Murohara, T; Numaguchi, Y; Okumura, K; Takahashi, R | 1 |
Asai, T; Matsui, H; Murakami, H; Murakami, R; Murohara, T; Numaguchi, Y; Okumura, K; Takahashi, R | 1 |
da Costa, KA; Mar, MH; Shin, OH; Zeisel, SH | 1 |
2 review(s) available for methacycline and Liver Steatosis
Article | Year |
---|---|
The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes.
Topics: Animals; Diabetes Mellitus, Type 2; Diglycerides; Fatty Liver; Humans; Hyperglycemia; Insulin Resistance; Lipid Metabolism; Lipids; Lipodystrophy; Lipogenesis; Liver; Muscle, Skeletal; Non-alcoholic Fatty Liver Disease; Triglycerides | 2014 |
Diacylglycerol activation of protein kinase Cε and hepatic insulin resistance.
Topics: Animals; Diabetes Mellitus, Type 2; Diglycerides; Fatty Liver; Humans; Insulin Resistance; Liver; Mice; Non-alcoholic Fatty Liver Disease; Protein Kinase C-epsilon | 2012 |
9 other study(ies) available for methacycline and Liver Steatosis
Article | Year |
---|---|
The influence of dexamethasone on hepatic fatty acids metabolism and transport in human steatotic HepG2 cell line exposed to palmitate.
Topics: Biological Transport; Ceramides; Dexamethasone; Diglycerides; Fatty Acids; Fatty Liver; Glucocorticoids; Hep G2 Cells; Humans; Lipid Metabolism; Liver; Liver Neoplasms; Palmitates; Triglycerides | 2021 |
Onset of Senescence and Steatosis in Hepatocytes as a Consequence of a Shift in the Diacylglycerol/Ceramide Balance at the Plasma Membrane.
Topics: Cell Membrane; Cellular Senescence; Ceramides; Diglycerides; Fatty Liver; Hep G2 Cells; Humans; Transferases (Other Substituted Phosphate Groups) | 2021 |
Inhibiting monoacylglycerol acyltransferase 1 ameliorates hepatic metabolic abnormalities but not inflammation and injury in mice.
Topics: Acyltransferases; Adipose Tissue; Adiposity; Animals; Biomarkers; Diet; Diglycerides; Fatty Acids; Fatty Liver; Gene Expression Regulation; Gene Knockdown Techniques; Glucose; Glucose Tolerance Test; Hepatic Stellate Cells; Homeostasis; Inflammation; Leukocytes; Lipogenesis; Liver; Male; Mice, Inbred C57BL; Mice, Obese; N-Acetylglucosaminyltransferases; Oligonucleotides, Antisense; Oxidation-Reduction; Triglycerides; Weight Gain | 2014 |
Second-generation antisense oligonucleotides against β-catenin protect mice against diet-induced hepatic steatosis and hepatic and peripheral insulin resistance.
Topics: Adipose Tissue, White; Animals; beta Catenin; Dietary Fats; Diglycerides; Fatty Acids; Fatty Liver; Glucose; Insulin; Insulin Resistance; Lipids; Liver; Male; Mice; Mice, Inbred C57BL; Oligonucleotides, Antisense; Protective Agents; Triglycerides | 2016 |
Hepatic steatosis by dietary-conjugated linoleic acid is accompanied by accumulation of diacylglycerol and increased membrane-associated protein kinase C ε in mice.
Topics: Animals; Diet; Diglycerides; Fatty Liver; Glucose; Glucose-6-Phosphatase; Hyperglycemia; Insulin Resistance; Linoleic Acids, Conjugated; Liver; Male; Mice; Mice, Inbred C57BL; Phosphoenolpyruvate Carboxykinase (ATP); Protein Kinase C-epsilon; Triglycerides | 2011 |
Impact of alpha-tocopherol on cardiac hypertrophy due to energy metabolism disorder: the involvement of 1,2-diacylglycerol.
Topics: alpha-Tocopherol; Animals; Diet; Diglycerides; Echocardiography; Energy Metabolism; Fatty Acids; Fatty Liver; Hemodynamics; Hypertrophy, Left Ventricular; Lipids; Mice; Mice, Inbred C3H; Mice, Mutant Strains; Models, Animal; Myocardium; Thiobarbituric Acid Reactive Substances | 2003 |
Dietary fish oil attenuates cardiac hypertrophy in lipotoxic cardiomyopathy due to systemic carnitine deficiency.
Topics: Animals; Blood Glucose; Cardiomyopathy, Hypertrophic; Carnitine; Cell Membrane; Dietary Fats, Unsaturated; Diglycerides; Echocardiography; Fatty Acids; Fatty Liver; Fish Oils; Membrane Lipids; Mice; Mice, Inbred C3H; Models, Animal; Myocardium; Protein Biosynthesis; Protein Kinase C | 2005 |
Combined therapy with PPARalpha agonist and L-carnitine rescues lipotoxic cardiomyopathy due to systemic carnitine deficiency.
Topics: Adenosine Triphosphate; Animals; Cardiomyopathy, Hypertrophic; Carnitine; Diglycerides; Drug Therapy, Combination; Echocardiography; Fatty Acids; Fatty Liver; Fenofibrate; Mice; Mice, Inbred C3H; Mice, Mutant Strains; Models, Animal; Myocardium; Peroxisome Proliferator-Activated Receptors; PPAR alpha; Protein Kinase C; Random Allocation; Treatment Outcome; Triglycerides | 2006 |
Hepatic protein kinase C is not activated despite high intracellular 1,2-sn-diacylglycerol in obese Zucker rats.
Topics: Animals; Cell Membrane; Choline; Diglycerides; Enzyme Activation; Fatty Liver; Liver; Obesity; Protein Kinase C; Rats; Rats, Zucker | 1997 |